PA
OM icon

Parallel Advisors’s Outset Medical OM Stock Holding History

Parallel Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$91 – 3396
2024
Q1 		$91 Hold
3
– – ﹤0.01% 3210
2023
Q4 		$222 Sell
3
-2
-40% -$163 ﹤0.01% 3159
2023
Q3 		$740 Sell
5
-4
-44% -$944 ﹤0.01% 3028
2023
Q2 		$3.02K Hold
9
– – ﹤0.01% 2609
2023
Q1 		$2.54K Sell
9
-4
-31% -$1.47K ﹤0.01% 2679
2022
Q4 		$4.85K Buy
+13
New +$3.67K ﹤0.01% 2353
2022
Q2 		– Sell
-2
Closed -$2K – 3246
2022
Q1 		$2K Buy
+2
New +$1.2K ﹤0.01% 2603
2021
Q4 		– Sell
-6
Closed -$5K – 3225
2021
Q3 		$5K Buy
+6
New +$4.09K ﹤0.01% 2373

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Parallel Advisors's OM Position: Q2 2024 in Review

Parallel Advisors sold out of Outset Medical (OM) in Q2 2024, closing a stake of 3 shares — an estimated $91 sold.

Parallel Advisors first reported a position in OM in Q3 2021 and held it in 8 quarters. The position peaked at $5K in Q3 2021. 122 funds tracked by Wall St. Rank hold OM as of Q2 2024.

  • Parallel Advisors reported no remaining Outset Medical position as of Q2 2024 after selling out during the quarter.
  • Parallel Advisors sold 3 Outset Medical shares in Q2 2024, an estimated $91.
  • Parallel Advisors first reported a position in Outset Medical in Q3 2021 and held it in 8 quarters.
  • Parallel Advisors's Outset Medical position peaked at $5K in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Outset Medical as of Q2 2024.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.